Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 ✓ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number : 001-36421 Alberta , Canada ( State or other jurisdiction of incorporation or organization ) Title of Each Class Common shares , no par value Common shares , no par value Form 10 - K # 1203-4464 Markham Street Victoria , British Columbia V8Z 7X8 ( Address of principal executive offices ) Large accelerated filer Non - accelerated filer Aurinia Pharmaceuticals Inc. ( Exact name of registrant as specified in its charter ) Registrant's telephone number , including area code : ( 250 ) 708-4272 Securities registered pursuant to Section 12 ( b ) of the Act : ✓ Symbol AUPH AUP Not applicable ( I.R.S. Employer Identification Number ) Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Indicate by check mark whether the registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No 46-4129078 Name of Each Exchange on Which Registered The Nasdaq Global Market LLC Toronto Stock Exchange Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer " , " smaller reporting company " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . ( Check one ) : DOCUMENTS INCORPORATED BY REFERENCE Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No The aggregate market value of the common shares held by non - affiliates of the registrant as of December 31 , 2020 totaled approximately $ 1.74 billion based on the closing price for the registrant's common shares on that day as reported by the Nasdaq Global Market . Such value excludes common shares held by executive officers , and directors as of December 31 , 2020 . As of February 24 , 2021 , there were 127,450,815 of the registrant's common shares outstanding . 0 0 0 Document Description Portions of the registrant's definitive proxy statement to be filed with the U.S. Securities and Exchange Commission pursuant to Regulation 14A within 120 days after registrant's fiscal year end of December 31 , 2020 are incorporated by reference into Part III of this Annual Report on Form 10 - K . 10 - K Part III